CT-95 — Interim data
Sep 2026
We expect to share Phase 1a interim data for the CT-95 trial in September 2026.Source filing
CONTEXT THERAPEUTICS INC · Data as of 2026-09-08
Sep 2026
We expect to share Phase 1a interim data for the CT-95 trial in September 2026.Source filing
Q2 2027
Q2 2027: Phase 1a initial Q3W dosing dataSource filing
H2 2027
We also expect to share initial Phase 1a data from the CT-202 trial in the second half of 2027.Source filing